TMSB4X Antibody, FITC conjugated

1. Serum Tbeta4 level can be used as a biomarker for the diagnosis of NASH and was negatively correlated with the oxidation state of the liver PMID:29271227
2. we suggest that overexpression of Tbeta4 might play a role in the progression of gastric gastrointestinal stromal tumors PMID:28756979
3. Tbeta4 exerts a protective effect on murine colitis, indicating that recombinant adeno-associated virus carrying thymosin beta4 could potentially be developed into a promising agent for the therapy of inflammatory bowel diseases. PMID:28127198
4. Results showed that the TMSB4 pseudogene, lncRNA-MSR, was upregulated in the damaged cartilage and was activated in chondrocytes in response to mechanical stress. Furthermore, lncRNA-MSR regulated the expression of TMSB4 by competing with miRNA-152 in chondrocytes. PMID:27469625
5. Tbeta4 gene silencing in A549 and H1299 cells inhibited cell proliferation, migration, and invasion in vitro and decreased tumor growth in vivo. Mechanistic investigations revealed a significant decrease in Notch1 activation in Tbeta4 gene-silenced cells. PMID:27521796
6. Developed an innovative biotechnological method for thymosin beta4 production that employs the peptide acetylation in vivo. PMID:27015974
7. Serum thymosin beta4 concentrations were correlated with the occurrence and severity of obstructive sleep apnea syndrome. PMID:27086675
8. Overexpression of Tbeta4 enhanced cell proliferation and colony formation in oral squamous cell carcinoma. PMID:26276576
9. Tbeta-4 was validated in clinical samples using a tissue microarray to predict overall survival in colon cancer patients PMID:26556858
10. this study demonstrated, for the first time, that Tbeta4 was down-regulated in ROS-stimulated PDLCs as well as Tbeta4 activation exhibited anti-inflammatory effects and anti-osteoclastogenesis in vitro. PMID:26789270
11. this study demonstrates, for the first time, that Tbeta4 is expressed in developing periodontal tissue and that its expression is associated with osteoblastic/cementoblastic differentiation. PMID:26361868
12. This article reviews the potential role of thymosin beta 4 in liver fibrosis by describing the effects of exogenous and endogenous thymosin beta 4 , and discusses the possible signaling pathway regulated by TB4X. [review] PMID:26006229
13. The results of the present study suggested that Tb4 may promote HB metastasis via the induction of EMT, and that Tb4 may therefore be a target for the development of novel treatments for patients with Hepatoblastoma . PMID:25695679
14. these results suggest that NO could regulate the expression of Tbeta4 by direct or indirect effect of HIF-1alpha on Tbeta4 promoter. PMID:25271630
15. the exchange of bound actin between Tbeta4 and profilin involves both steric and allosteric components. PMID:25313062
16. Thymosin beta4 induces invasion and migration of human colorectal cancer cells through the ILK/AKT/beta-catenin signaling pathway. PMID:25218472
17. Regarding HCC, Tbeta4 reactivity was detected in 7/23 cases (30%) and Tbeta10 reactivity in 22/23 (97%) cases analyzed, adding HCC to human cancers that express these beta-thymosins. PMID:24704991
18. Thymosin beta-4 levels in the serum and synovial fluid of knee osteoarthritis patients are significantly correlated with disease severity. PMID:23816466
19. Thymosin beta 4 silencing in glioblastoma cells inhibits cell migration and invasion. PMID:24355709
20. cell trafficking of thymosin beta-4 PMID:23967050
21. Tbeta4 expression was upregulated significantly in primary and recurrent colorectal cancers PMID:24098025
22. Tbeta4 expression was also co-localized with CD133 expression in primary ovarian carcinomas. PMID:23055022
23. Detection its amino acid conservation suggest an important role of Tb4 in the homeostasis of the mammalian oral cavity. PMID:23262355
24. Thymosin beta4 could be associated with morphogenesis and tumor invasion in ameloblastoma and may play a role in the behavior of ameloblastoma. PMID:23235961
25. Tbeta4 plays a key role in odontoblastic differentiation of human dental pulp cells. PMID:23613983
26. Tbeta4 is an important myocardin-related transcription factor (MRTF) regulator that controls the G-actin-MRTF-A interaction.Tbeta4 competed with MRTF-A for G-actin binding, thus interfering with G-actin-MRTF-A complex formation. PMID:23811404
27. REVIEW: role of Tbeta4 in thrombosis and platelet aggregation PMID:22944663
28. Thymosin beta4 expression reveals intriguing similarities between fetal and cancer cells. PMID:23045970
29. investigated whether GSK-3 activity is regulated by thymosin beta-4 (Tbeta4) and associated with Tbeta4-mediated migration in gastric cancer cells; expression of GSK-3alpha, beta-catenin and E-cadherin could be negatively regulated by Tbeta4 induced ERK phosphorylation; suggests that Tbeta4 could be a novel regulator to control Wnt signal pathway PMID:22328534
30. The Our data confirm the concept that externally added Tbeta4 must be internalized to induce intracellular mechanisms supporting endothelial cell migration. PMID:22652458
31. Thymosin beta4 Tbeta4 may play an important role in bone degradation and inflammation in RA but not OA. PMID:22004227
32. kininogen-1 and thymosin-beta(4) are potential new biomarkers for human chronic hepatitis C. PMID:21496200
33. Tbeta4 is regulated by IL-18 and is involved in IL-18-enhanced IFN-gamma secretion in NK cells. PMID:21742406
34. Elevated expression of thymosin beta4 is associated with early-stage cervical cancers. PMID:21213129
35. Thymosin beta4 may play a role in diabetic retinal neovascularization. PMID:21332672
36. findings suggest that Tbeta4 by sequestering actin prevents binding of AKT, thus inhibiting its phosphorylation PMID:21514425
37. The expression of thymosin beta4 is highly related with tumorigenesis of certain tumors including the osteosarcoma and colorectal cancers. PMID:20975530
38. Describe beta-thymosins in bronchoalveolar lavage fluid and their possible involvement in the pathogenesis of scleroderma lung disease. PMID:21314931
39. we have identified an extracellular signaling pathway where Tbeta4 increases cell surface ATP levels via ATP synthase and have shown further that ATP-responsive P2X4 receptor is required for Tbeta4-induced cell migration PMID:21106936
40. overexpression of Tbeta4 is strongly associated with HIF-1alpha and HIF-2alpha expression and is also clinicopathologically involved with lymph node metastatic potential of breast cancer PMID:21109953
41. The TB4 could be a hypoxia responsive regulator to control tumor cell migration in angiogenesis and tumor metastasis. PMID:20821256
42. colorectal cancer stem cells from different patients have higher Tbeta4 levels than normal epithelial cells PMID:20566622
43. Data in colon cancer tissue microarray showed that thymosin beta4 and HIF-1alpha co-localized in these biopsies. PMID:20691219
44. Data show a strong expression of Tbeta(4) in gut and endocrine pancreas during development. PMID:20161756
45. study demonstrated a clear relationship between reductions in serum thymosin beta4 level and severity of hepatitis B virus-related liver failure PMID:20128033
46. Data show that thymosin beta4 was differentially expressed in HGF-treated HUVECs compared with control. PMID:12163032
47. araC regulates the transcriptional level of thymosin beta4 and actin PMID:12962156
48. in response to T beta 4 stimulation, AP-1 activity increases to enhance PAI-1 transcription through its unique AP-1-like element at -59 to -52 in the PAI-1 promoter. PMID:14592829
49. upregulation of Tbeta-4, by promoting the disruption of cell-cell adhesion and consequential activation of the beta-catenin signaling, could be event in the acquisition of growth advantages as well as invasive phenotypes in human colorectal carcinomas PMID:15235586
50. activated factor XIII incorporates thymosin beta(4) into the isolated gamma-module and alphaC-domain (fibrinogen A alpha); in fibrin the latter serves as the major incorporation site PMID:15311936

Show More

Hide All

HGNC: 11881

UNIGENE: Hs.437277

KEGG: hsa:7114

STRING: 9606.ENSP00000370007

OMIM: 300159